Dheerendra Kommala, MD
Chief Strategy Officer
Dheerendra Kommala, MD, joined ECRI in 2019 as Chief Strategy Officer. In this new role, Dr. Kommala is responsible for setting the organization’s strategic direction. He drives business development opportunities by identifying and acting on market and industry prospects, and by interacting with healthcare organizations, government agencies, and regulatory authorities.
Dr. Kommala brings more than 20 years of experience as an academic clinician, researcher, and chief medical officer. He successfully introduced new products and services to markets throughout the world by working collaboratively with major health systems, industry leaders, clinicians, and patients. Throughout his career, he has been a vocal advocate for patient safety and a visionary leader managing large teams.
Prior to joining ECRI, Dr. Kommala was global vice president of medical affairs for Baxter Healthcare. Previous experience included working as chief medical officer/global vice president of medical affairs for ConvaTec, and as associate medical director of Global Pharmaceutical Research for Renal Care, Abbott Laboratories.
Dr. Kommala received his initial medical training in India, and completed a fellowship in nephrology at the University of Missouri, Columbia School of Medicine.